Kaletra Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)
Condition:   COVID-19 Interventions:   Drug: Chloroquine or Hydroxychloroquine;   Drug: Lopinavir/Ritonavir;   Other: Best standard of care;   Drug: Rivaroxaban;   Drug: Thromboprophylaxis;   Drug: Candesartan;   Drug: non-RAS blocking antihypertensives;   Drug: Clazakizumab;   Drug: placebo for clazakizumab Sponsors:   Medical University of Vienna;   Kaiser Franz Josef Hospital;   SMZ-Ost Donauspital;   Otto Wagner Hospital;   Hospital Hietzing;   Wilhelminenspital Vienna;   Medical University Innsbruck Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2020 Category: Research Source Type: clinical trials

Austrian CoronaVirus Adaptive Clinical Trial
Condition:   COVID Interventions:   Drug: Chloroquine or Hydroxychloroquine;   Drug: Lopinavir/Ritonavir;   Other: Best standard of care;   Drug: Rivaroxaban;   Drug: Thromboprophylaxis;   Drug: Candesartan;   Drug: non-RAS blocking antihypertensives;   Drug: Clazakizumab;   Drug: placebo for clazakizumab Sponsors:   Medical University of Vienna;   Kaiser Franz Josef Hospital;   SMZ-Ost Donauspital;   Otto Wagner Hospital;   Hospital Hietzing;   Wilhelminenspital Vienna;   Medical University Innsbruck Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2020 Category: Research Source Type: clinical trials

Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19
Condition:   COVID-19 Pneumonia Interventions:   Drug: Hidroxicloroquine;   Drug: Lopinavir/ritonavir;   Drug: Imatinib tablets;   Drug: Baricitinib Oral Tablet Sponsors:   Hospital Universitario de Fuenlabrada;   Centro Nacional de Investigaciones Oncologicas CARLOS III Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2020 Category: Research Source Type: clinical trials

Clinical Trial to Evaluate the Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19
Condition:   COVID-19 Pneumonia Interventions:   Drug: Hidroxicloroquine;   Drug: Lopinavir/ritonavir;   Drug: Imatinib tablets;   Drug: Baricitinib Oral Tablet Sponsors:   Hospital Universitario de Fuenlabrada;   Centro Nacional de Investigaciones Oncologicas CARLOS III Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2020 Category: Research Source Type: clinical trials

Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19
Condition:   COVID-19 Pneumonia Interventions:   Drug: Hidroxicloroquine;   Drug: Lopinavir/ritonavir;   Drug: Imatinib tablets;   Drug: Baricitinib Oral Tablet Sponsors:   Hospital Universitario de Fuenlabrada;   Centro Nacional de Investigaciones Oncologicas CARLOS III Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2020 Category: Research Source Type: clinical trials